Apnimed, Inc. APMD
IPO
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -85.76% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -85.76% | ||||
| Cost of Revenue | -43.98% | ||||
| Gross Profit | -86.85% | ||||
| SG&A Expenses | 94.80% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 41.82% | ||||
| Operating Income | -117.20% | ||||
| Income Before Tax | 79.21% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 79.21% | ||||
| Earnings from Discontinued Operations | 93.29% | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 85.97% | ||||
| EBIT | -117.20% | ||||
| EBITDA | -117.19% | ||||
| EPS Basic | 110.80% | ||||
| Normalized Basic EPS | 113.30% | ||||
| EPS Diluted | 157.16% | ||||
| Normalized Diluted EPS | 150.53% | ||||
| Average Basic Shares Outstanding | -11.78% | ||||
| Average Diluted Shares Outstanding | -24.89% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||